Entering text into the input field will update the search result below

Enanta Pharmaceuticals, Inc. (ENTA) CEO Jay Luly on Q1 2019 Results - Earnings Call Transcript

Feb. 06, 2019 9:57 PM ETEnanta Pharmaceuticals, Inc. (ENTA)
SA Transcripts profile picture
SA Transcripts

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Q1 2019 Earnings Conference Call February 6, 2019 4:30 PM ET

Company Participants

Carol Miceli - Investor Relations

Jay Luly - President, Chief Executive Officer and Director

Paul Mellett - Senior Vice President, Finance and Administration and Chief Financial Officer

Conference Call Participants

Brian Abrahams - RBC Capital Markets

Yasmeen Rahimi - ROTH Capital Partners

Jay Olson - Oppenheimer

Liisa Bayko - JMP Securities

Eric Joseph - JPMorgan

Patrick Trucchio - Berenberg Capital Markets


Good day. My name is Ian, and I will be your conference operator today. At this time, I would like to welcome everyone to the Enanta Pharmaceuticals' First Quarter Financial Results Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question-and-answer session. [Operator Instructions]

Thank you. I would now like to turn the call over to Carol Miceli. Ma'am, you may begin.

Carol Miceli

Thank you, Ian, and thanks for joining us this afternoon. The news release with our financial results for the recent quarter was issued and is available on our website. On the call today is Dr. Jay Luly, President and Chief Executive Officer; Paul Mellett, our Chief Financial Officer; and other members of Enanta's senior management team.

But before we begin with our formal remarks, we want to remind you that we'll be making forward-looking statements, which may include our plans and expectations with respect to our product candidates and financial projections, all of which involve certain assumptions and risks beyond our control that could cause our actual developments and results to differ materially from those statements. A description of these risks is in our most recent Form 10-K and other periodic reports filed with the SEC. Enanta does not undertake any obligation to update any forward-looking statements made during

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.